BUY IPCA Laboratories Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)2 Jun 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·10 Jul · 3d ago
IPCA Laboratories Limited's Board approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd. with Ipca Laboratories Ltd. The merger aims for operational synergies, cost optimization,
NSE · Outcome of Board Meeting·26 Jun · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Vikas Sethi, Sethi Finmart23 Oct 2026 · ~1 year · target ₹2,250 · Active
- BUY — Kunal Saraogi23 Oct 2026 · ~3 months · target ₹2,350 · Active
- BUY — Manas Jaiswal22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY — Vikas Sethi, Sethi Finmart8 Oct 2026 · ~1 year · target ₹2,300 · SL hit
- BUY — Sudeep Shah, SBICAP Securities5 Oct 2026 · ~3 months · target ₹2,040 · SL hit
More from ICICI Securities
- BUY CIE Automotive India23 Oct 2026 · ~1 year · target ₹475 · Active
- BUY SAGILITY23 Oct 2026 · ~1 year · target ₹55 · Active
- BUY CREDITACCESS GRAMEEN23 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Havells India23 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Balkrishna Industries22 Oct 2026 · ~1 year · target ₹2,675 · Active

